XML 38 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Plans and Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option
A summary of stock option activity under the 2010 Plan and Inducement Awards are summarized as follows:
Number of
Shares
Weighted
Average
Exercise
Price per
Share
Weighted
Average
Remaining Contractual Life
Aggregate Intrinsic Value
Outstanding, December 31, 20241,160,251 $33.44 7.19$— 
Granted1,388,400 3.04 
Exercised— — 
Canceled/Forfeited(122,121)10.57 
Outstanding, June 30, 2025
2,426,530 $17.30 8.17$— 
Exercisable at June 30, 2025
774,125 $45.01 5.64$— 
Vested and unvested expected to vest at June 30, 2025
2,426,530 $17.30 8.17$— 
Schedule of Valuation Assumptions Used to Calculate Fair Value of Employee Options Awarded the following estimated assumptions under the Black-Scholes option pricing model:
Six Months Ended
June 30,
 20252024
Expected term (years) 6.06.0
Risk free interest rate
3.9% - 4.4%
3.9% - 4.3%
Expected volatility
113% - 114%
114% - 116%
Expected dividendsNoneNone
Schedule of Restricted Stock Awards
The following table presents a summary of RSAs under the 2010 Plan as of June 30, 2025:
Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 202440,137 $18.20 
Awarded— — 
Vested(39,637)18.20 
Forfeited(500)18.20 
Unvested, June 30, 2025
— $— 
The following table presents a summary of RSUs under the 2010 Plan as of June 30, 2025:
Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2024— $— 
Awarded350,600 3.13 
Vested— — 
Forfeited(67,100)3.13 
Unvested, June 30, 2025
283,500 3.13 
Schedule of Stock-Based Compensation Expense
For the three and six months ended June 30, 2025 and 2024, the Company recorded stock-based compensation expense to the following line items in its costs and expenses section of the Condensed Consolidated Statements of Operations and Comprehensive Loss:
 Three Months Ended
June 30,
Six Months Ended
June 30,
(in thousands)2025202420252024
Research and development$492 $737 $1,084 $1,546 
General and administrative643 967 1,215 1,717 
Total stock-based compensation expense$1,135 $1,704 $2,299 $3,263